UPCOMING MCAB MEETING 9/26

UPCOMING MCAB MEETING 9/26

A computer monitor displaying a video conference call with multiple participants, a keyboard, a mouse, and a small potted plant on a wooden desk in a dimly lit room.

Let them hear you.


The Medical Cannabis Advisory Board (MCAB) meets on September 26th to review how West Virginia’s medical cannabis program is working and recommend changes to improve it. The Board is made up of doctors, patient advocates, and industry representatives who advise the Office of Medical Cannabis and the Legislature on important issues like:

  • Patient access and affordability

  • Product variety and quality

  • Rules and regulations that impact care

This meeting is one of the few times patients and the public can directly influence the direction of the program. If you’ve faced challenges - whether with product access, pricing, or program rules - this is your chance to speak up. Sharing your story helps the Board understand how real patients are affected and where changes are needed.

Access the Meeting here on September 26th @ 12pm
Email the MCAB your Feedback
Exterior view of a modern wooden door with a black handle, set in a dark frame, during dusk or early evening.

There’s a closed door meeting happening Aug 25: for the OMC and Industry Partners only.

THIS MEETING HAS PASSED.

The West Virginia Office of Medical Cannabis (OMC) has issued a new technical advisory that redefines how strain names are regulated. Previously, strain names were not considered part of product labeling. Now, they are being scrutinized under strict packaging rules - prohibiting names that resemble food, candy, alcohol, or anything deemed inappropriate for a medical product by the OMC’s subjective and opaque standards.

Why This Matters:

Patients were excluded: There was no effort to include patient voices, even though these changes affect how they identify and access products.

Transparency is at risk: The new rules could limit the use of familiar strain names, making it harder for patients to understand what they’re purchasing.

Missed opportunity for feedback: Many stakeholders who would have submitted comments were left out and now may not have a say in the final guidance.

While it may be too late for the OMC to listen, the Medical Cannabis Advisory Board has a meeting on September 26th at 12PM.

They will be accepting comments through at least Monday August 25th. Send in your feedback to medcanwv@wv.gov

THIS MEETING HAS PASSED.